Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ·Healthcare·Biotechnology
$3.58
-2.72%
Mkt Cap $975.36M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $49.05M | $49.87M | +1.67% | -$0.07 | -$0.04 | +42.86% | — | — |
| Q4 2025 Nov 6, 2025 | $49.06M | $41.63M | -15.15% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q3 2025 Aug 11, 2025 | $50.08M | $47.40M | -5.36% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q2 2025 May 12, 2025 | $44.01M | $46.85M | +6.46% | -$0.07 | -$0.08 | -14.29% | — | — |
| Q1 2025 Mar 18, 2025 | $57.79M | $56.41M | -2.39% | -$0.03 | -$0.06 | -100.00% | — | — |
| Q4 2024 Nov 7, 2024 | $56.64M | $65.20M | +15.10% | -$0.01 | -$0.02 | -150.00% | — | — |
| Q3 2024 Aug 7, 2024 | $71.63M | $73.40M | +2.47% | -$0.04 | -$0.08 | -100.00% | — | — |
| Q2 2024 May 8, 2024 | $60.55M | $64.18M | +5.99% | -$0.02 | -$0.02 | -21.43% | — | — |
| Q1 2024 Feb 22, 2024 | $64.38M | $74.14M | +15.16% | $0.00 | $0.01 | +184.90% | — | — |
| Q4 2023 Nov 7, 2023 | $75.52M | $66.86M | -11.46% | -$0.00 | -$0.01 | -257.14% | — | — |
| Q3 2023 Aug 7, 2023 | $71.13M | $68.91M | -3.12% | -$0.03 | -$0.06 | -100.00% | — | — |
| Q2 2023 May 8, 2023 | $79.72M | $79.03M | -0.87% | $0.04 | $0.03 | -17.24% | — | — |
| Q1 2023 Feb 22, 2023 | $204.93M | $204.71M | -0.10% | $0.34 | $0.35 | +2.94% | — | — |
| Q4 2022 Nov 2, 2022 | $195.11M | $191.26M | -1.97% | $0.32 | $0.37 | +15.62% | — | — |
| Q3 2022 Aug 4, 2022 | $233.22M | $242.73M | +4.08% | $0.45 | $0.54 | +20.00% | — | — |
| Q2 2022 May 5, 2022 | $232.29M | $244.29M | +5.17% | $0.44 | $0.54 | +22.73% | — | — |
| Q1 2022 Feb 23, 2022 | $208.09M | $228.44M | +9.78% | $0.38 | $0.45 | +18.42% | — | — |
| Q4 2021 Nov 10, 2021 | $152.14M | $204.81M | +34.62% | $0.35 | $0.44 | +25.71% | — | — |
| Q3 2021 Aug 10, 2021 | $194.81M | $217.78M | +11.79% | $0.32 | $0.44 | +37.50% | — | — |
| Q2 2021 May 10, 2021 | $112.92M | $148.21M | +31.25% | $0.21 | $0.26 | +23.81% | — | — |